Epidemiology of a fast emerging disease in the Asia-Pacific region: non-alcoholic fatty liver disease (Q40707692)

22 September 2017

Epidemiology of a fast emerging disease in the Asia-Pacific region: non-alcoholic fatty liver disease (English)

1 reference

non-alcoholic fatty liver

22 September 2017

1 reference

metabolic dysfunction–associated steatotic liver disease

inferred from title

1 reference

Chan Wah-Kheong

1

1 reference

PubMed ID

26201622

22 September 2017

Goh Khean-Lee

series ordinal

2

1 reference

22 September 2017

15 June 2012

1 reference

22 September 2017

Hepatology international

1 reference

22 September 2017

7

1 reference

22 September 2017

1

1 reference

22 September 2017

65-71

1 reference

https://scigraph.springernature.com/pub.10.1007/s12072-012-9384-1

22 September 2017

0 references

cites work

Relationship between alanine aminotransferase levels and metabolic syndrome in nonalcoholic fatty liver disease

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Prevalence of metabolic syndrome and its associations with other metabolic disorders and cardiovascular changes in health examination population in Beijing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Prevalence of and risk factors for fatty liver disease in a professional population of Wuhan, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Fatty liver and the metabolic syndrome among Shanghai adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Prevalence and risk factors of fatty liver disease in the Shuiguohu district of Wuhan city, central China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Intake of n-3 polyunsaturated fatty acids and non-alcoholic fatty liver disease: a cross-sectional study in Japanese men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Correlation between fatty liver and coronary risk factors: a population study of elderly men and women in Nagasaki, Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Impact of nonalcoholic fatty liver disease on insulin resistance in relation to HbA1c levels in nondiabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Gout and risk of non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Metabolic syndrome as a risk factor for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Significant correlations between severe fatty liver and risk factors for metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Sonographic fatty liver, overweight and ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Nonalcoholic fatty liver disease in Japanese junior high school students: its prevalence and relationship to lifestyle habits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Non-alcoholic fatty liver disease prevalence among school-aged children and adolescents in Iran and its association with biochemical and anthropometric measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Fatty liver predicts impaired fasting glucose and type 2 diabetes mellitus in Japanese undergoing a health checkup

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Presence of coronary plaques in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Evaluation of metabolic syndrome frequency and carotid artery intima-media thickness as risk factors for atherosclerosis in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Nonalcoholic steatohepatitis and increased risk of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Prevalence and risk factors of gallstone disease in an adult population of Taiwan: an epidemiological survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Prevalence and risk factors of hepatic steatosis and its impact on liver injury in Chinese patients with chronic hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Hepatic steatosis and fibrosis in young men with treatment-naïve chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Hepatic steatosis in chronic hepatitis C virus infection: prevalence and clinical correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Insulin resistance, steatosis, and fibrosis in Egyptian patients with chronic Hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Hepatic steatosis in Iranian patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12072-012-9384-1

Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C.

21 January 2018

1 reference

12 December 2020

Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes.

1 reference

12 December 2020

[Prevalence of nonalcoholic fatty liver disease and metabolic syndrome in obese children].

1 reference

12 December 2020

Epidemiological survey of prevalence of fatty liver and its risk factors in a general adult population of Shanghai

1 reference

12 December 2020

Study on prevalence and risk factors of fatty liver of patients with type 2 diabetes

1 reference

12 December 2020

Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults

1 reference

12 December 2020

Prevalence of non-alcoholic fatty liver disease: population based study.

1 reference

12 December 2020

Abdominal sonographic screening in a single community

1 reference

12 December 2020

Prevalence of nonalcoholic fatty liver disease in coastal eastern India: a preliminary ultrasonographic survey.

1 reference

12 December 2020

Prevalence of fatty liver disease and its risk factors in the population of South China

1 reference

12 December 2020

Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures

1 reference

12 December 2020

[The prevalence of non-alcoholic fatty liver disease and its related risk factors in 1180 school children in Shanghai]

1 reference

12 December 2020

Nonalcoholic steatohepatitis in obese children: the prevalence and possible mechanism

1 reference

12 December 2020

Non-alcoholic fatty liver disease's prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese

1 reference

12 December 2020

Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study

1 reference

12 December 2020

Relationship of non-alcoholic fatty liver disease to colorectal adenomatous polyps

1 reference

12 December 2020

Impairment of the left ventricular systolic and diastolic function in patients with non-alcoholic fatty liver disease

1 reference

12 December 2020

Frequency of abnormalities detected by upper abdominal ultrasound.

1 reference

12 December 2020

Prevalence and risk factors of non-alcoholic fatty liver disease in a multiracial suburban Asian population in Malaysia

1 reference

12 December 2020

A study on fatty liver in health examination participants

1 reference

12 December 2020

Prevalence and risk factors of fatty liver disease in Chengdu, Southwest China.

1 reference

12 December 2020

Epidemiological survey of the association between non alcoholic fatty liver disease and metabolic syndrome in civil servants of Chongqing city

1 reference

12 December 2020

Nonalcoholic fatty liver disease is a risk factor for type 2 diabetes in middle-aged Japanese men

1 reference

12 December 2020

Nonalcoholic fatty liver disease in overweight children and adolescents

1 reference

12 December 2020

Sonographic fatty liver in overweight and obese children, a cross sectional study in Isfahan

1 reference

12 December 2020

Epidemiology of fatty liver in a hospital-based study in Taiwan

1 reference

12 December 2020

The importance of metabolic factors for the increasing prevalence of fatty liver in Shanghai factory workers

1 reference

12 December 2020

10.1007/S12072-012-9384-1

Identifiers

DOI

1 reference

22 September 2017

1 reference

PubMed ID

26201622